Originally published by our sister publication Pharmacy Practice News
The number of reports about serious adverse events (AEs) among patients exposed to fentanyl, heroin and other illicit drugs contaminated with xylazine are increasing, according to the FDA, which issued a warning to healthcare providers.
Stimulants (e.g., methamphetamine and cocaine) also have been combined with xylazine. Xylazine-containing products may be sold under the street names tranq, tranq dope, sleep-cut, Philly dope